Investors can access the audio portion of the presentation on the UBS Warburg
website at http://www.ubswarburg.com. The audio portion will be available live
and by replay. The replay will begin 24 hours after the actual presentation and
will be available until March 7, 2002.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2000 Form 10-K and subsequent filings.
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X27577222
CONTACT: Gary Samuels, Media, +1-201-393-5700, or Cathy Doherty,
Investors, +1-201-393-5030, both of Quest Diagnostics
URL: http://www.questdiagnostics.com
http://www.prnewswire.com
Copyright (C) 2002 PR Newswire. All rights reserved.